Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine

Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine

Bibliographic Details
Main Authors: Jose W. Ricardo, MD, Shari R. Lipner, MD, PhD
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:JAAD Case Reports
Subjects:
adverse reaction
Beau lines
COVID-19
nail psoriasis
nails
onycholysis
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512621006433

Internet

http://www.sciencedirect.com/science/article/pii/S2352512621006433

Similar Items